Electrical Engineer I/II

Brisbane, CA
May 16, 2022
Biotech Bay
Required Education
Bachelors Degree
Position Type
Full time
Mammoth is seeking an Electrical Engineer I/II with Printed Circuit Board (PCB) design experience.  You will work in a diverse, dynamic, multifunctional team to package our novel CRISPR enzymes into a molecular diagnostics system.  The successful candidate will have experience with board level design and bring up.  The position will require creativity and outside of box thinking with strong technical and analytical skills.
  • Design electrical board-level schematic 
  • Prepare and implement test planning and test execution
  • Conduct environmental testing, qualification of development and production hardware
  • Interface with vendors to qualify electronic components to be included in the instrument, manage Printed Circuit Board Assembly (PCBA) manufacturers, and establish incoming inspection practices 
  • Design and build test fixtures for component and subsystem testing
  • Work with cross functional teams to enable high volume manufacturing

  • BS in Electrical Engineering with a minimum of 3 years of experience 
  • Experience with designing and troubleshoot at the board level
  • Experience with power and motion control systems

  • MS in Electrical Engineering
  • Proficiency in Altium Designer
  • Experience integrating Radio Frequency (RF) systems (Buletooth, WiFi)
  • Experience with optical systems (camera, photodiode, etc.)
  • Experience with Python, C, or C#
  • Familiarity with microcontroller and single board computer design
  • Ability to think critically with demonstrated troubleshooting and problem solving
  • Excellent interpersonal, verbal, and written communication skills

  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Decheng, Mayfield, NFX, and 8VC, along with leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

The Diagnostics team is advancing our CRISPR-based DETECTR® platform to address unmet needs across the continuum of testing. From laboratories to the home, our mission is to democratize diagnostics with CRISPR. 

It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law.  This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.

Mammoth Biosciences requires that all employees be vaccinated against Covid-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law.